category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,Annotation,ontology
ARA:PWY-5807,0.0029122910714672184,0.9999983012029166,1,5,heptaprenyl diphosphate biosynthesis,BioCyc
ARA:GLYCOLYSIS,0.029244422555820132,0.9997868158791557,1,57,glycolysis I (from glucose 6-phosphate),BioCyc
ARA:PWY66-399,0.03238403781282266,0.9997377860457026,1,62,gluconeogenesis III,BioCyc
ARA:PWY-5484,0.03253509643420411,0.9997352455254627,1,63,glycolysis II (from fructose 6-phosphate),BioCyc
ARA:ALACAT2-PWY,1,0.9937868269062146,0,12,L-alanine degradation II (to D-lactate),BioCyc
ARA:ALANINE-DEG3-PWY,1,0.9958592306486123,0,8,L-alanine degradation III,BioCyc
ARA:ALANINE-SYN2-PWY,1,0.9958592306486123,0,8,L-alanine biosynthesis II,BioCyc
ARA:ARG-PRO-PWY,1,0.9978415397796349,0,4,L-arginine degradation VI (arginase 2 pathway),BioCyc
ARA:ARGASEDEG-PWY,1,0.9984879000608219,0,3,L-arginine degradation I (arginase pathway),BioCyc
ARA:ARGDEG-V-PWY,1,0.9985187619056368,0,3,L-arginine degradation X (arginine monooxygenase pathway),BioCyc
ARA:ARGININE-SYN4-PWY,1,0.9969556766937264,0,6,L-ornithine biosynthesis II,BioCyc
ARA:ARGSPECAT-PWY,1,0.9937810263254537,0,11,spermine biosynthesis,BioCyc
ARA:ARGSYN-PWY,1,0.9914336384095563,0,16,L-arginine biosynthesis I (via L-ornithine),BioCyc
ARA:ARGSYNBSUB-PWY,1,0.9919499364904651,0,15,L-arginine biosynthesis II (acetyl cycle),BioCyc
ARA:ASPARAGINE-BIOSYNTHESIS,1,0.9970937131148196,0,6,L-asparagine biosynthesis I,BioCyc
ARA:ASPARAGINE-DEG1-PWY,1,0.9966229153876841,0,6,L-asparagine degradation I,BioCyc
ARA:ASPARAGINESYN-PWY,1,0.9970937131148196,0,6,L-asparagine biosynthesis II,BioCyc
ARA:ASPARTATE-DEG1-PWY,1,0.9931307578879146,0,14,L-aspartate degradation I,BioCyc
ARA:ASPARTATESYN-PWY,1,0.9931307578879146,0,14,L-aspartate biosynthesis,BioCyc
ARA:ASPASN-ARA-PWY,1,0.9868739363353778,0,26,superpathway of aspartate and asparagine biosynthesis,BioCyc
ARA:ASPSYNII-PWY,1,0.9948548599005416,0,10,cyanide detoxification I,BioCyc
ARA:BRANCHED-CHAIN-AA-SYN-PWY,1,0.9810709184835744,0,37,superpathway of branched chain amino acid biosynthesis,BioCyc
ARA:BSUBPOLYAMSYN-PWY,1,0.9932624393303194,0,12,spermidine biosynthesis I,BioCyc
ARA:CALVIN-PWY,1,0.9783175828259111,0,39,Calvin-Benson-Bassham cycle,BioCyc
ARA:CAMALEXIN-SYN,1,0.9841449038676909,0,29,camalexin biosynthesis,BioCyc
ARA:CHLOROPHYLL-SYN,1,0.9880123583688153,0,22,"3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)",BioCyc
ARA:CITRULBIO-PWY,1,0.9820122526402232,0,35,L-citrulline biosynthesis,BioCyc
ARA:CITRULLINE-DEG-PWY,1,0.9994595377222456,0,1,L-citrulline degradation,BioCyc
ARA:COA-PWY,1,0.9946036470002925,0,9,coenzyme A biosynthesis I,BioCyc
ARA:COMPLETE-ARO-ARA-PWY,1,0.9802558374128825,0,38,"superpathway of phenylalanine, tyrosine and tryptophan biosynthesis",BioCyc
ARA:CYANCAT-PWY,1,0.9982704494422694,0,3,cyanate degradation,BioCyc
ARA:CYSTSYN-PWY,1,0.986578448070074,0,25,L-cysteine biosynthesis I,BioCyc
ARA:DETOX1-PWY,1,0.9890583849412207,0,21,superoxide radicals degradation,BioCyc
ARA:ETHYL-PWY,1,0.9836632353035607,0,31,ethylene biosynthesis I (plants),BioCyc
ARA:ETOH-ACETYLCOA-ANA-PWY,1,0.9938542964224082,0,12,ethanol degradation I,BioCyc
ARA:FASYN-ELONG-PWY,1,0.9911605199791942,0,15,fatty acid elongation -- saturated,BioCyc
ARA:GLNSYN-PWY,1,0.9949330849062121,0,10,L-glutamine biosynthesis I,BioCyc
ARA:GLUCONEO-PWY,1,0.9690060455847207,0,60,gluconeogenesis I,BioCyc
ARA:GLUCOSE1PMETAB-PWY,1,0.9898104417081599,0,21,glucose and glucose-1-phosphate degradation,BioCyc
ARA:GLUGLNSYN-PWY,1,0.9985866975336262,0,3,L-glutamate biosynthesis IV,BioCyc
ARA:GLUT-REDOX-PWY,1,0.9980680458706871,0,4,glutathione-glutaredoxin redox reactions,BioCyc
ARA:GLUTAMATE-DEG1-PWY,1,0.997923290024642,0,4,L-glutamate degradation I,BioCyc
ARA:GLUTAMATE-SYN2-PWY,1,0.997923290024642,0,4,L-glutamate biosynthesis II,BioCyc
ARA:GLUTAMINDEG-PWY,1,0.9855285164120685,0,28,L-glutamine degradation I,BioCyc
ARA:GLUTATHIONESYN-PWY,1,0.9985447034355317,0,3,glutathione biosynthesis,BioCyc
ARA:GLUTORN-PWY,1,0.9939494556785193,0,11,L-ornithine biosynthesis I,BioCyc
ARA:GLUTSYNIII-PWY,1,0.996959423412934,0,6,L-glutamate biosynthesis III,BioCyc
ARA:GLYCLEAV-PWY,1,0.9907770125085325,0,17,glycine cleavage,BioCyc
ARA:GLYOXDEG-PWY,1,0.9990215357037061,0,2,glycolate and glyoxylate degradation II,BioCyc
ARA:GLYOXYLATE-BYPASS,1,0.9910714591277676,0,17,glyoxylate cycle,BioCyc
ARA:GLYSYN-ALA-PWY,1,0.9940008509405305,0,12,glycine biosynthesis III,BioCyc
ARA:GLYSYN-PWY,1,0.994411065179201,0,11,glycine biosynthesis I,BioCyc
ARA:GLYSYN2-PWY,1,0.9899274767174066,0,20,glycine biosynthesis,BioCyc
ARA:HEME-BIOSYNTHESIS-II,1,0.9928971242647999,0,14,heme biosynthesis I (aerobic),BioCyc
ARA:HEXPPSYN-PWY,1,0.9989678436548516,0,2,hexaprenyl diphosphate biosynthesis,BioCyc
ARA:HISTSYN-PWY,1,0.9917744048494685,0,16,L-histidine biosynthesis,BioCyc
ARA:HOMOCYSDEGR-PWY,1,0.9994844831230318,0,1,L-cysteine biosynthesis III (from L-homocysteine),BioCyc
ARA:HOMOSER-THRESYN-PWY,1,0.9974452178183049,0,4,L-threonine biosynthesis,BioCyc
ARA:HOMOSERSYN-PWY,1,0.9951413483799397,0,10,L-homoserine biosynthesis,BioCyc
ARA:ILE-VAL-PWY,1,0.9906738038507946,0,19,superpathway of isoleucine and valine biosynthesis,BioCyc
ARA:ILEUDEG-PWY,1,0.9895336494252903,0,20,L-isoleucine degradation I,BioCyc
ARA:ILEUSYN-PWY,1,0.9940543055867683,0,12,L-isoleucine biosynthesis I (from threonine),BioCyc
ARA:KDOSYN-PWY,1,0.9990002742521092,0,2,Kdo transfer to lipid IVA I,BioCyc
ARA:LCYSDEG-PWY,1,0.9994374078668596,0,1,L-cysteine degradation II,BioCyc
ARA:LEU-DEG2-PWY,1,0.98353722502932,0,32,L-leucine degradation I,BioCyc
ARA:LEUSYN-PWY,1,0.9859153406802597,0,27,L-leucine biosynthesis,BioCyc
ARA:LIPAS-PWY,1,0.9518189432899649,0,93,triacylglycerol degradation,BioCyc
ARA:LIPASYN-PWY,1,0.9624851089434524,0,72,phospholipases,BioCyc
ARA:LYSINE-DEG2-PWY,1,0.9940463245116896,0,12,lysine degradation II,BioCyc
ARA:MALATE-ASPARTATE-SHUTTLE-PWY,1,0.9893935913117181,0,21,L-aspartate degradation II,BioCyc
ARA:MANNCAT-PWY,1,0.9978976958089618,0,4,D-mannose degradation,BioCyc
ARA:MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS,1,0.9865069680527874,0,25,"protein N-glycosylation (eukaryotic, high mannose)",BioCyc
ARA:METHIONINE-DEG1-PWY,1,0.9951373503409006,0,9,L-methionine degradation I (to L-homocysteine),BioCyc
ARA:NAGLIPASYN-PWY,1,0.9940390110136353,0,11,lipid IVA biosynthesis,BioCyc
ARA:NONMEVIPP-PWY,1,0.9920404730113711,0,15,methylerythritol phosphate pathway I,BioCyc
ARA:NONOXIPENT-PWY,1,0.9911017992215215,0,16,pentose phosphate pathway (non-oxidative branch),BioCyc
ARA:OXIDATIVEPENT-PWY,1,0.9891624818367694,0,20,pentose phosphate pathway (oxidative branch) I,BioCyc
ARA:P401-PWY,1,0.9953505075824232,0,9,cyanide degradation,BioCyc
ARA:PANTO-PWY,1,0.9963380461477803,0,7,phosphopantothenate biosynthesis I,BioCyc
ARA:PENTOSE-P-PWY,1,0.9803127378466562,0,36,pentose phosphate pathway,BioCyc
ARA:PHOSLIPSYN2-PWY,1,0.9969461817121017,0,6,superpathway of phospholipid biosynthesis II (plants),BioCyc
ARA:PHOTOALL-PWY,1,0.9486354727634884,0,85,oxygenic photosynthesis,BioCyc
ARA:PLPSAL-PWY,1,0.997418078422499,0,5,pyridoxal 5'-phosphate salvage I,BioCyc
ARA:POLYAMINSYN3-PWY,1,0.9984842571442654,0,3,superpathway of polyamine biosynthesis II,BioCyc
ARA:PROSYN-PWY,1,0.9983876544619196,0,3,L-proline biosynthesis I,BioCyc
ARA:PROUT-PWY,1,0.9980256997829272,0,4,L-proline degradation,BioCyc
ARA:PWY-1001,1,0.9903423426718855,0,20,cellulose biosynthesis,BioCyc
ARA:PWY-101,1,0.9699882417694565,0,46,photosynthesis light reactions,BioCyc
ARA:PWY-102,1,0.9951968182801355,0,9,gibberellin inactivation I (2&beta;-hydroxylation),BioCyc
ARA:PWY-1042,1,0.9719134598627042,0,55,glycolysis IV (plant cytosol),BioCyc
ARA:PWY-1061,1,0.9847721976452504,0,29,homogalacturonan biosynthesis,BioCyc
ARA:PWY-1081,1,0.9801678781316789,0,38,homogalacturonan degradation,BioCyc
ARA:PWY-112,1,0.9972438253290178,0,5,lupeol biosynthesis,BioCyc
ARA:PWY-1121,1,0.9706074536264682,0,54,suberin monomers biosynthesis,BioCyc
ARA:PWY-116,1,0.9978394263418087,0,4,coniferin metabolism,BioCyc
ARA:PWY-1186,1,0.9959568273718259,0,8,L-homomethionine biosynthesis,BioCyc
ARA:PWY-1187,1,0.98190687235715,0,31,glucosinolate biosynthesis from homomethionine,BioCyc
ARA:PWY-1269,1,0.9954307246908174,0,9,CMP-3-deoxy-D-manno-octulosonate biosynthesis,BioCyc
ARA:PWY-1422,1,0.9950979955778888,0,9,vitamin E biosynthesis (tocopherols),BioCyc
ARA:PWY-1581,1,0.9965848457061408,0,6,plastoquinol-9 biosynthesis I,BioCyc
ARA:PWY-1722,1,0.9957155252869777,0,8,"formate assimilation into 5,10-methylenetetrahydrofolate",BioCyc
ARA:PWY-1782,1,0.9921726212098987,0,15,superpathway of indole-3-acetate conjugate biosynthesis,BioCyc
ARA:PWY-1801,1,0.9989543561672765,0,2,formaldehyde oxidation II (glutathione-dependent),BioCyc
ARA:PWY-181,1,0.98080903824605,0,36,photorespiration,BioCyc
ARA:PWY-1822,1,0.9962398139404155,0,7,indole-3-acetate activation I,BioCyc
ARA:PWY-1881,1,0.9995015783884269,0,1,formate oxidation to CO2,BioCyc
ARA:PWY-2,1,0.9985314149004999,0,3,putrescine degradation IV,BioCyc
ARA:PWY-2021,1,0.9949429455691059,0,10,indole-3-acetate degradation IV,BioCyc
ARA:PWY-2161,1,0.9919740961936605,0,16,folate polyglutamylation,BioCyc
ARA:PWY-2161B,1,0.9969395295778584,0,6,glutamate removal from folates,BioCyc
ARA:PWY-2161B-PMN,1,0.99498878726073,0,10,folate polyglutamylation II,BioCyc
ARA:PWY-2181,1,0.9972417338203111,0,5,free phenylpropanoid acid biosynthesis,BioCyc
ARA:PWY-2261,1,0.9851402386940756,0,26,ascorbate glutathione cycle,BioCyc
ARA:PWY-2301,1,0.9969490337298548,0,6,myo-inositol biosynthesis,BioCyc
ARA:PWY-2501,1,0.9927050543931498,0,15,fatty acid &alpha;-oxidation I,BioCyc
ARA:PWY-2541,1,0.977104035139526,0,44,plant sterol biosynthesis,BioCyc
ARA:PWY-2582,1,0.9958758874530188,0,8,brassinosteroid biosynthesis II,BioCyc
ARA:PWY-2602,1,0.99927288937477865,0,1,brassinosteroid biosynthesis III,BioCyc
ARA:PWY-2681,1,0.9907918695359302,0,17,trans-zeatin biosynthesis,BioCyc
ARA:PWY-2724,1,0.9941550068133638,0,12,alkane oxidation,BioCyc
ARA:PWY-2781,1,0.9990187875444594,0,2,cis-zeatin biosynthesis,BioCyc
ARA:PWY-282,1,0.9953541262013967,0,8,cuticular wax biosynthesis,BioCyc
ARA:PWY-2821,1,0.989616901345963,0,18,glucosinolate biosynthesis from phenylalanine,BioCyc
ARA:PWY-2841,1,0.9965518864036674,0,7,cytokinins degradation,BioCyc
ARA:PWY-2881,1,0.9960977414783041,0,7,cytokinins 7-N-glucoside biosynthesis,BioCyc
ARA:PWY-2901,1,0.9960977414783041,0,7,cytokinins 9-N-glucoside biosynthesis,BioCyc
ARA:PWY-2902,1,0.9956608148707851,0,8,cytokinin-O-glucosides biosynthesis,BioCyc
ARA:PWY-3001,1,0.9793601654962495,0,41,superpathway of L-isoleucine biosynthesis I,BioCyc
ARA:PWY-3041,1,0.9979228560495784,0,4,monoterpene biosynthesis,BioCyc
ARA:PWY-3101,1,0.9936960664224107,0,11,flavonol biosynthesis,BioCyc
ARA:PWY-3181,1,0.9975891386353254,0,5,L-tryptophan degradation VI (via tryptamine),BioCyc
ARA:PWY-321,1,0.9806481413772334,0,35,cutin biosynthesis,BioCyc
ARA:PWY-3221,1,0.9994289330694422,0,1,dTDP-L-rhamnose biosynthesis II,BioCyc
ARA:PWY-3261,1,0.9979444020442186,0,4,UDP-L-rhamnose biosynthesis,BioCyc
ARA:PWY-3301,1,0.980028125005164,0,39,sinapate ester biosynthesis,BioCyc
ARA:PWY-3341,1,0.9979021679387537,0,4,L-proline biosynthesis III,BioCyc
ARA:PWY-3385,1,0.9929575475320358,0,14,choline biosynthesis I,BioCyc
ARA:PWY-3461,1,0.9952367646747852,0,9,L-tyrosine biosynthesis II,BioCyc
ARA:PWY-3462,1,0.9930847341861174,0,13,L-phenylalanine biosynthesis II,BioCyc
ARA:PWY-3481,1,0.9914514231684558,0,16,superpathway of L-phenylalanine and L-tyrosine biosynthesis,BioCyc
ARA:PWY-3561,1,0.9873189232806082,0,26,choline biosynthesis III,BioCyc
ARA:PWY-361,1,0.9711998932178536,0,54,phenylpropanoid biosynthesis,BioCyc
ARA:PWY-3742,1,0.9838641266533599,0,30,tetrahydrofolate biosynthesis II,BioCyc
ARA:PWY-3781,1,0.935680048859873,0,104,aerobic respiration I (cytochrome c),BioCyc
ARA:PWY-3801,1,0.9792712993034575,0,41,sucrose degradation II (sucrose synthase),BioCyc
ARA:PWY-381,1,0.9934597341427083,0,13,nitrate reduction II (assimilatory),BioCyc
ARA:PWY-3821,1,0.995920298087894,0,8,D-galactose degradation III,BioCyc
ARA:PWY-3841,1,0.9804031052627181,0,38,folate transformations II,BioCyc
ARA:PWY-3881,1,0.9963059170630483,0,7,mannitol biosynthesis,BioCyc
ARA:PWY-3941,1,0.9972217741876885,0,5,&beta;-alanine biosynthesis II,BioCyc
ARA:PWY-3982,1,0.998464735985088,0,3,uracil degradation I (reductive),BioCyc
ARA:PWY-4,1,0.9985485284248478,0,3,UDP-D-galacturonate biosynthesis II (from D-galacturonate),BioCyc
ARA:PWY-40,1,0.9985187619056368,0,3,putrescine biosynthesis I,BioCyc
ARA:PWY-401,1,0.9955735127364116,0,9,galactolipid biosynthesis I,BioCyc
ARA:PWY-4041,1,0.9939447826852588,0,11,&gamma;-glutamyl cycle,BioCyc
ARA:PWY-4081,1,0.9914997011903921,0,15,glutathione-peroxide redox reactions,BioCyc
ARA:PWY-4101,1,0.9905949052302914,0,17,D-sorbitol degradation I,BioCyc
ARA:PWY-4203,1,0.9983376189163143,0,3,volatile benzenoid biosynthesis I (ester formation),BioCyc
ARA:PWY-4221ARA,1,0.990951596269373,0,16,superpathway of pantothenate and coenzymeA biosynthesis,BioCyc
ARA:PWY-4261,1,0.9990020250318505,0,2,glycerol degradation I,BioCyc
ARA:PWY-43,1,0.996971656044741,0,6,putrescine biosynthesis II,BioCyc
ARA:PWY-4302,1,0.9472850302713766,0,84,aerobic respiration III (alternative oxidase pathway),BioCyc
ARA:PWY-4321,1,0.9939150179506224,0,12,L-glutamate degradation IV,BioCyc
ARA:PWY-4341,1,0.9990605041189315,0,2,L-glutamate biosynthesis V,BioCyc
ARA:PWY-4361,1,0.9892967523216767,0,20,S-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,BioCyc
ARA:PWY-4381,1,0.9929085752017286,0,14,fatty acid biosynthesis initiation I,BioCyc
ARA:PWY-4541,1,0.9950240945147479,0,9,"lipid-dependent phytate biosynthesis I (via Ins(1,4,5)P3)",BioCyc
ARA:PWY-4562,1,0.9920030542522934,0,15,"lipid-dependent phytate biosynthesis II (via Ins(1,3,4)P3)",BioCyc
ARA:PWY-4661,1,0.9928489360449323,0,14,1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza),BioCyc
ARA:PWY-4702,1,0.9979506608194322,0,4,phytate degradation I,BioCyc
ARA:PWY-4765,1,0.9920030542522934,0,15,superpathway of lipid-dependent phytate biosynthesis,BioCyc
ARA:PWY-4821,1,0.9903419132755498,0,18,UDP-D-xylose biosynthesis,BioCyc
ARA:PWY-4841,1,0.996317895367208,0,7,UDP-&alpha;-D-glucuronate biosynthesis (from myo-inositol),BioCyc
ARA:PWY-4861,1,0.996656813369346,0,6,UDP-D-galacturonate biosynthesis I (from UDP-D-glucuronate),BioCyc
ARA:PWY-4983,1,0.9974829042042396,0,5,L-citrulline-nitric oxide cycle,BioCyc
ARA:PWY-4984,1,0.9969336825609085,0,6,urea cycle,BioCyc
ARA:PWY-5027,1,0.9976705978989973,0,4,phylloquinol biosynthesis,BioCyc
ARA:PWY-5032,1,0.9995169329822393,0,1,ent-kaurene biosynthesis I,BioCyc
ARA:PWY-5034,1,0.9980087730450421,0,4,GA12 biosynthesis,BioCyc
ARA:PWY-5035,1,0.9922317735015339,0,14,gibberellin biosynthesis III (early C-13 hydroxylation),BioCyc
ARA:PWY-5036,1,0.9988362222548686,0,2,gibberellin biosynthesis II (early C-3 hydroxylation),BioCyc
ARA:PWY-5041,1,0.9922481503603222,0,15,S-adenosyl-L-methionine cycle II,BioCyc
ARA:PWY-5043,1,0.9919679842807011,0,15,purine nucleosides salvage II (plant),BioCyc
ARA:PWY-5046,1,0.9910678845983807,0,17,2-oxoisovalerate decarboxylation to isobutanoyl-CoA,BioCyc
ARA:PWY-5049,1,0.9993940860202699,0,1,rosmarinic acid biosynthesis II,BioCyc
ARA:PWY-5060,1,0.9978241676915349,0,4,luteolin biosynthesis,BioCyc
ARA:PWY-5063,1,0.9994712408660927,0,1,phytyl diphosphate biosynthesis,BioCyc
ARA:PWY-5064,1,0.9989836385574911,0,2,chlorophyll a biosynthesis II,BioCyc
ARA:PWY-5068,1,0.9970328863451602,0,6,chlorophyll cycle,BioCyc
ARA:PWY-5070,1,0.9947988576029235,0,9,"gibberellin biosynthesis I (non C-3, non C-13 hydroxylation)",BioCyc
ARA:PWY-5079,1,0.9959051244833849,0,8,L-phenylalanine degradation III,BioCyc
ARA:PWY-5080,1,0.9781312828332909,0,41,very long chain fatty acid biosynthesis I,BioCyc
ARA:PWY-5083,1,0.9560345562441609,0,70,NAD/NADH phosphorylation and dephosphorylation,BioCyc
ARA:PWY-5084,1,0.992144760829665,0,15,2-oxoglutarate decarboxylation to succinyl-CoA,BioCyc
ARA:PWY-5086,1,0.9995122687148206,0,1,chlorophyll a biosynthesis I,BioCyc
ARA:PWY-5097,1,0.9904139907708005,0,19,L-lysine biosynthesis VI,BioCyc
ARA:PWY-5098,1,0.9962060897470386,0,7,chlorophyll a degradation I,BioCyc
ARA:PWY-5107,1,0.9989066591080765,0,2,phytol salvage pathway,BioCyc
ARA:PWY-5111,1,0.9960447577020138,0,8,CMP-KDO biosynthesis II (from D-arabinose 5-phosphate),BioCyc
ARA:PWY-5113,1,0.9990075753200484,0,2,UDP-D-apiose biosynthesis (from UDP-D-glucuronate),BioCyc
ARA:PWY-5114,1,0.9795208708142039,0,39,UDP-sugars interconversion,BioCyc
ARA:PWY-5115,1,0.9995061407291206,0,1,GDP-L-galactose biosynthesis,BioCyc
ARA:PWY-5120,1,0.9911304466227295,0,14,geranylgeranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5121,1,0.9807099771900686,0,34,superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP),BioCyc
ARA:PWY-5122,1,0.9902298922911906,0,16,geranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5123,1,0.9877243631828281,0,21,"trans, trans-farnesyl diphosphate biosynthesis",BioCyc
ARA:PWY-5125,1,0.995537772054508,0,8,anthocyanin biosynthesis,BioCyc
ARA:PWY-5129,1,0.9834298164140988,0,32,sphingolipid biosynthesis (plants),BioCyc
ARA:PWY-5136,1,0.9927377253379179,0,14,fatty acid &beta;-oxidation II (peroxisome),BioCyc
ARA:PWY-5138,1,0.9942316679005115,0,10,"unsaturated, even numbered fatty acid &beta;-oxidation",BioCyc
ARA:PWY-5142,1,0.9968319900007104,0,6,acyl-ACP thioesterase pathway,BioCyc
ARA:PWY-5143,1,0.9911533000381312,0,17,long-chain fatty acid activation,BioCyc
ARA:PWY-5147,1,0.9844436902875436,0,30,oleate biosynthesis I (plants),BioCyc
ARA:PWY-5148,1,0.99478403428212,0,8,acyl-CoA hydrolysis,BioCyc
ARA:PWY-5152,1,0.9943407279751223,0,10,leucodelphinidin biosynthesis,BioCyc
ARA:PWY-5168,1,0.9979185501295512,0,4,ferulate and sinapate biosynthesis,BioCyc
ARA:PWY-5172,1,0.996062792546626,0,8,acetyl-CoA biosynthesis III (from citrate),BioCyc
ARA:PWY-5175,1,0.9995074404384519,0,1,lactucaxanthin biosynthesis,BioCyc
ARA:PWY-5176,1,0.999516078310501,0,1,coumarin biosynthesis (via 2-coumarate),BioCyc
ARA:PWY-5188,1,0.993333434327134,0,13,tetrapyrrole biosynthesis I (from glutamate),BioCyc
ARA:PWY-5194,1,0.9973303213047708,0,5,siroheme biosynthesis,BioCyc
ARA:PWY-5203,1,0.9951073621424048,0,9,soybean saponin I biosynthesis,BioCyc
ARA:PWY-5267,1,0.9952238407765073,0,9,glucosinolate activation,BioCyc
ARA:PWY-5269,1,0.9966428635147462,0,6,cardiolipin biosynthesis II,BioCyc
ARA:PWY-5271,1,0.9989847687087761,0,2,phaseic acid biosynthesis,BioCyc
ARA:PWY-5272,1,0.9947001500252116,0,9,abscisic acid glucose ester metabolism,BioCyc
ARA:PWY-5285,1,0.9989113711551867,0,2,sulfide oxidation III (persulfide dioxygenase),BioCyc
ARA:PWY-5287,1,0.9994533761622537,0,1,sanguinarine and macarpine biosynthesis,BioCyc
ARA:PWY-5313,1,0.9976553652108779,0,4,superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside),BioCyc
ARA:PWY-5320,1,0.9909989435939613,0,16,kaempferol glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5321,1,0.9744731848024831,0,44,quercetin glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5326,1,0.9989429424769223,0,2,sulfite oxidation IV,BioCyc
ARA:PWY-5337,1,0.993753965778848,0,12,stachyose biosynthesis,BioCyc
ARA:PWY-5340,1,0.994439308247588,0,10,sulfate activation for sulfonation,BioCyc
ARA:PWY-5342,1,0.9995169311581866,0,1,ajugose biosynthesis I (galactinol-dependent),BioCyc
ARA:PWY-5343,1,0.9995106648833906,0,1,ajugose biosynthesis II (galactinol-independent),BioCyc
ARA:PWY-5350,1,0.9943098566627843,0,8,thiosulfate disproportionation IV (rhodanese),BioCyc
ARA:PWY-5366,1,0.9968319900007104,0,6,palmitoleate biosynthesis II (plants and bacteria),BioCyc
ARA:PWY-5377,1,0.9977262968638811,0,4,&alpha;-amyrin biosynthesis,BioCyc
ARA:PWY-5381,1,0.9772436368792685,0,40,pyridine nucleotide cycling (plants),BioCyc
ARA:PWY-5386,1,0.9888339090872605,0,22,methylglyoxal degradation I,BioCyc
ARA:PWY-5389,1,0.9981622145357919,0,3,3-methylthiopropanoate biosynthesis,BioCyc
ARA:PWY-5391,1,0.9948590088830409,0,9,syringetin biosynthesis,BioCyc
ARA:PWY-5410,1,0.9954960391131181,0,8,traumatin and (Z)-3-hexen-1-yl acetate biosynthesis,BioCyc
ARA:PWY-5441,1,0.9974930431853102,0,5,S-methyl-L-methionine cycle,BioCyc
ARA:PWY-5453,1,0.9920457252948205,0,13,methylglyoxal degradation III,BioCyc
ARA:PWY-5466,1,0.998408574331156,0,3,matairesinol biosynthesis,BioCyc
ARA:PWY-5469,1,0.9988126394830835,0,2,sesamin biosynthesis,BioCyc
ARA:PWY-5481,1,0.9993837674147839,0,1,pyruvate fermentation to lactate,BioCyc
ARA:PWY-5486,1,0.9918009908561947,0,16,pyruvate fermentation to ethanol II,BioCyc
ARA:PWY-5530,1,0.9967271409553574,0,5,sorbitol biosynthesis II,BioCyc
ARA:PWY-561,1,0.98218258458328,0,32,superpathway of glyoxylate cycle and fatty acid degradation,BioCyc
ARA:PWY-5640,1,0.9993801895955844,0,1,nitrobenzene degradation II,BioCyc
ARA:PWY-5659,1,0.9898819473757577,0,20,GDP-mannose biosynthesis,BioCyc
ARA:PWY-5661,1,0.9922556298020963,0,16,GDP-glucose biosynthesis,BioCyc
ARA:PWY-5667,1,0.9874062504631402,0,25,CDP-diacylglycerol biosynthesis I,BioCyc
ARA:PWY-5669,1,0.9975689418570237,0,5,phosphatidylethanolamine biosynthesis I,BioCyc
ARA:PWY-5670,1,0.9965798025829219,0,7,epoxysqualene biosynthesis,BioCyc
ARA:PWY-5686,1,0.9969972895385129,0,6,UMP biosynthesis I,BioCyc
ARA:PWY-5687,1,0.9797848227831366,0,38,pyrimidine ribonucleotides interconversion,BioCyc
ARA:PWY-5690,1,0.9773582939261659,0,41,TCA cycle II (plants and fungi),BioCyc
ARA:PWY-5691,1,0.9982555510636231,0,3,urate degradation to allantoin I,BioCyc
ARA:PWY-5692,1,0.999020131491537,0,2,allantoin degradation to glyoxylate II,BioCyc
ARA:PWY-5697,1,0.9990236677029328,0,2,allantoin degradation to ureidoglycolate I (urea producing),BioCyc
ARA:PWY-5698,1,0.9980491861058022,0,4,allantoin degradation to ureidoglycolate II (ammonia producing),BioCyc
ARA:PWY-5704,1,0.9995169881556226,0,1,urea degradation II,BioCyc
ARA:PWY-5723,1,0.9779487322950559,0,41,Rubisco shunt,BioCyc
ARA:PWY-5765,1,0.9979140097679489,0,4,"1,3,5-trimethoxybenzene biosynthesis",BioCyc
ARA:PWY-5783,1,0.9989678436548516,0,2,octaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-5788,1,0.9949429455691059,0,10,indole-3-acetate degradation V,BioCyc
ARA:PWY-5791,1,0.9949402031595725,0,9,"1,4-dihydroxy-2-naphthoate biosynthesis II (plants)",BioCyc
ARA:PWY-5800,1,0.9927353630657478,0,14,xylan biosynthesis,BioCyc
ARA:PWY-5805,1,0.9989678436548516,0,2,nonaprenyl diphosphate biosynthesis I,BioCyc
ARA:PWY-581,1,0.9836528876121565,0,31,indole-3-acetate biosynthesis II,BioCyc
ARA:PWY-5837,1,0.9949402031595725,0,9,"1,4-dihydroxy-2-naphthoate biosynthesis",BioCyc
ARA:PWY-5859,1,0.9932981308459385,0,11,eugenol and isoeugenol biosynthesis,BioCyc
ARA:PWY-5868,1,0.9848740322875169,0,28,simple coumarins biosynthesis,BioCyc
ARA:PWY-5871,1,0.9960447939366923,0,8,ubiquinol-9 biosynthesis (eukaryotic),BioCyc
ARA:PWY-5876,1,0.9989738122208187,0,2,magnoflorine biosynthesis,BioCyc
ARA:PWY-5884,1,0.9870307875588783,0,22,wax esters biosynthesis I,BioCyc
ARA:PWY-5886,1,0.997971298887266,0,4,4-hydroxyphenylpyruvate biosynthesis,BioCyc
ARA:PWY-5905,1,0.9982118378445536,0,3,hypusine biosynthesis,BioCyc
ARA:PWY-5921,1,0.9950606516363448,0,9,glutaminyl-tRNAgln biosynthesis via transamidation,BioCyc
ARA:PWY-5934,1,0.9927402094966481,0,14,iron reduction and absorption,BioCyc
ARA:PWY-5936,1,0.986093086393863,0,26,xyloglucan biosynthesis,BioCyc
ARA:PWY-5943,1,0.9994364683531433,0,1,&beta;-carotene biosynthesis,BioCyc
ARA:PWY-5944,1,0.9994618875188676,0,1,zeaxanthin biosynthesis,BioCyc
ARA:PWY-5945,1,0.9979387787962303,0,4,"zeaxanthin, antheraxanthin and violaxanthin interconversion",BioCyc
ARA:PWY-5946,1,0.9995074404384519,0,1,&delta;-carotene biosynthesis,BioCyc
ARA:PWY-5947,1,0.9980090676981755,0,4,lutein biosynthesis,BioCyc
ARA:PWY-5957,1,0.9979742830513506,0,3,L-nicotianamine biosynthesis,BioCyc
ARA:PWY-5963,1,0.9943669760316527,0,11,thio-molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-5971,1,0.9765764835907493,0,43,palmitate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5973,1,0.9853580337580294,0,26,cis-vaccenate biosynthesis,BioCyc
ARA:PWY-5980,1,0.9827770961567792,0,33,xylogalacturonan biosynthesis,BioCyc
ARA:PWY-5986,1,0.9988875514311109,0,2,ammonium transport,BioCyc
ARA:PWY-5989,1,0.9775499335268092,0,41,stearate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5992,1,0.9774432493626678,0,42,thalianol and derivatives biosynthesis,BioCyc
ARA:PWY-5995,1,0.9984606700640648,0,3,linoleate biosynthesis I (plants),BioCyc
ARA:PWY-5997,1,0.9985078112248533,0,3,&alpha;-linolenate biosynthesis I (plants and red algae),BioCyc
ARA:PWY-5998,1,0.9992116317514181,0,1,&gamma;-linolenate biosynthesis I (plants),BioCyc
ARA:PWY-6,1,0.9990339825019294,0,2,GDP-L-fucose biosynthesis II (from L-fucose),BioCyc
ARA:PWY-6005,1,0.999516979535236,0,1,marneral biosynthesis,BioCyc
ARA:PWY-6007,1,0.9990360190613762,0,2,arabidiol biosynthesis,BioCyc
ARA:PWY-601,1,0.9831184875780081,0,30,glucosinolate biosynthesis from tryptophan,BioCyc
ARA:PWY-6012,1,0.9977964832919001,0,4,acyl carrier protein metabolism,BioCyc
ARA:PWY-6014,1,0.9971668569347656,0,5,vernolate biosynthesis I,BioCyc
ARA:PWY-6019,1,0.9979187528849499,0,4,pseudouridine degradation,BioCyc
ARA:PWY-6039,1,0.9882738459369927,0,21,chlorogenic acid biosynthesis I,BioCyc
ARA:PWY-6040,1,0.9932501121011378,0,12,chlorogenic acid biosynthesis II,BioCyc
ARA:PWY-6051,1,0.9955618235718042,0,8,"2,4,6-trinitrotoluene degradation",BioCyc
ARA:PWY-6064,1,0.9988989883298908,0,2,methylquercetin biosynthesis,BioCyc
ARA:PWY-6066,1,0.9989810484048341,0,2,IAA biosynthesis VII,BioCyc
ARA:PWY-6115,1,0.9953176701422304,0,9,"avenacin biosynthesis, initial reactions",BioCyc
ARA:PWY-6118,1,0.9959930944573029,0,8,glycerol-3-phosphate shuttle,BioCyc
ARA:PWY-6121,1,0.9963071532762596,0,7,5-aminoimidazole ribonucleotide biosynthesis I,BioCyc
ARA:PWY-6122,1,0.9963071532762596,0,7,5-aminoimidazole ribonucleotide biosynthesis II,BioCyc
ARA:PWY-6124,1,0.9970531201786511,0,6,inosine-5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6132,1,0.9990343133292019,0,2,lanosterol biosynthesis,BioCyc
ARA:PWY-6137,1,0.9969702552203167,0,6,copper transport II,BioCyc
ARA:PWY-6147,1,0.9962898319453717,0,6,6-hydroxymethyl-dihydropterin diphosphate biosynthesis I,BioCyc
ARA:PWY-6163,1,0.9954368185032366,0,9,chorismate biosynthesis from 3-dehydroquinate,BioCyc
ARA:PWY-6164,1,0.997457117644028,0,5,3-dehydroquinate biosynthesis I,BioCyc
ARA:PWY-6196,1,0.9988646106312057,0,2,D-serine metabolism,BioCyc
ARA:PWY-6199,1,0.9952905376596433,0,7,quercetin sulfate biosynthesis,BioCyc
ARA:PWY-621,1,0.984919012344917,0,29,sucrose degradation III (sucrose invertase),BioCyc
ARA:PWY-6213,1,0.9971035340172824,0,6,cadmium transport I,BioCyc
ARA:PWY-6219,1,0.9949429455691059,0,10,indole-3-acetyl-amide conjugate biosynthesis,BioCyc
ARA:PWY-622,1,0.9840104136519627,0,33,starch biosynthesis,BioCyc
ARA:PWY-6220,1,0.9975281222132766,0,5,jasmonoyl-amino acid conjugates biosynthesis I,BioCyc
ARA:PWY-6232,1,0.9994116099101726,0,1,chrysoeriol biosynthesis,BioCyc
ARA:PWY-6233,1,0.9975281222132766,0,5,jasmonoyl-amino acid conjugates biosynthesis II,BioCyc
ARA:PWY-6235,1,0.9977519190462434,0,4,hydroxyjasmonate sulfate biosynthesis,BioCyc
ARA:PWY-6239,1,0.9994644523222532,0,1,luteolin glycosides biosynthesis,BioCyc
ARA:PWY-6266,1,0.9744731848024831,0,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6266-ARA,1,0.9744731848024831,0,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6287,1,0.9966047067577533,0,7,neurosporene biosynthesis,BioCyc
ARA:PWY-6295,1,0.9987235365274497,0,2,olivetol biosynthesis,BioCyc
ARA:PWY-63,1,0.9945066607690057,0,11,UDP-L-arabinose biosynthesis I (from UDP-xylose),BioCyc
ARA:PWY-6303,1,0.9974301520284459,0,5,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY-6304,1,0.9979231545963834,0,4,casbene biosynthesis,BioCyc
ARA:PWY-6305,1,0.9979756286992164,0,4,putrescine biosynthesis IV,BioCyc
ARA:PWY-6317,1,0.9926588838932799,0,15,D-galactose degradation I (Leloir pathway),BioCyc
ARA:PWY-6333,1,0.9938542964224082,0,12,acetaldehyde biosynthesis I,BioCyc
ARA:PWY-6348,1,0.9847356443059315,0,27,phosphate acquisition,BioCyc
ARA:PWY-6351,1,0.9737324617205128,0,52,"D-myo-inositol (1,4,5)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6352,1,0.9694432437005015,0,63,3-phosphoinositide biosynthesis,BioCyc
ARA:PWY-6363,1,0.9898823949723707,0,20,"D-myo-inositol (1,4,5)-trisphosphate degradation",BioCyc
ARA:PWY-6364,1,0.994153098505518,0,12,"D-myo-inositol (1,3,4)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6367,1,0.9926898782527723,0,14,D-myo-inositol-5-phosphate metabolism,BioCyc
ARA:PWY-6369,1,0.9964630150232263,0,7,inositol pyrophosphates biosynthesis,BioCyc
ARA:PWY-6406,1,0.9990339537092825,0,2,salicylate biosynthesis I,BioCyc
ARA:PWY-641,1,0.9978799186392996,0,4,proanthocyanidins biosynthesis from flavanols,BioCyc
ARA:PWY-6424,1,0.9987775529569896,0,2,"26,27-dehydrozymosterol metabolism",BioCyc
ARA:PWY-6441,1,0.9940774039923298,0,12,spermine and spermidine degradation III,BioCyc
ARA:PWY-6442,1,0.9969696988302312,0,5,spermidine hydroxycinnamic acid conjugates biosynthesis,BioCyc
ARA:PWY-6443,1,0.9692112582605739,0,54,"benzoate biosynthesis I (CoA-dependent, &beta;-oxidative)",BioCyc
ARA:PWY-6444,1,0.992701683710362,0,15,"benzoate biosynthesis II (CoA-independent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6446,1,0.9899633771230079,0,20,"benzoate biosynthesis III (CoA-dependent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6457,1,0.9957960535639572,0,8,trans-cinnamoyl-CoA biosynthesis,BioCyc
ARA:PWY-6466,1,0.9961143425697928,0,6,pyridoxal 5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6473,1,0.9985511629772678,0,3,4-aminobutanoate degradation IV,BioCyc
ARA:PWY-6475,1,0.9934933138974683,0,13,trans-lycopene biosynthesis II (plants),BioCyc
ARA:PWY-6483,1,0.9951319150058304,0,10,ceramide degradation,BioCyc
ARA:PWY-6498,1,0.9961698504406041,0,6,eumelanin biosynthesis,BioCyc
ARA:PWY-6502,1,0.9991940070164065,0,1,oxidized GTP and dGTP detoxification,BioCyc
ARA:PWY-6520,1,0.9979941339771639,0,4,nonaprenyl diphosphate biosynthesis II,BioCyc
ARA:PWY-6527,1,0.9935113049205785,0,13,stachyose degradation,BioCyc
ARA:PWY-6535,1,0.9985511629772678,0,3,4-aminobutanoate degradation I,BioCyc
ARA:PWY-6543,1,0.9971923001315355,0,5,4-aminobenzoate biosynthesis,BioCyc
ARA:PWY-6544,1,0.9944209000022198,0,11,superpathway of C28 brassinosteroid biosynthesis,BioCyc
ARA:PWY-6545,1,0.9835113573615064,0,29,pyrimidine deoxyribonucleotides de novo biosynthesis III,BioCyc
ARA:PWY-6546,1,0.9946702621552476,0,9,brassinosteroids inactivation,BioCyc
ARA:PWY-6549,1,0.9813211116014527,0,37,L-glutamine biosynthesis III,BioCyc
ARA:PWY-6554,1,0.9920030542522934,0,15,"1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)",BioCyc
ARA:PWY-6556,1,0.9980874203500392,0,3,pyrimidine ribonucleosides salvage II,BioCyc
ARA:PWY-6577,1,0.9984910445608853,0,3,farnesylcysteine salvage pathway,BioCyc
ARA:PWY-6596,1,0.9885876986907922,0,23,adenosine nucleotides degradation I,BioCyc
ARA:PWY-6599,1,0.9986617285841587,0,2,guanine and guanosine salvage II,BioCyc
ARA:PWY-66,1,0.9962162451161306,0,6,GDP-L-fucose biosynthesis I (from GDP-D-mannose),BioCyc
ARA:PWY-6605,1,0.9933017645492472,0,13,adenine and adenosine salvage II,BioCyc
ARA:PWY-6606,1,0.9919490054400454,0,16,guanosine nucleotides degradation II,BioCyc
ARA:PWY-6607,1,0.9925546158810962,0,15,guanosine nucleotides degradation I,BioCyc
ARA:PWY-6612,1,0.9934873492135746,0,11,superpathway of tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6613,1,0.9956456067747765,0,8,"tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate",BioCyc
ARA:PWY-6614,1,0.9960575864177699,0,8,tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6619,1,0.9990263768327922,0,2,adenine and adenosine salvage VI,BioCyc
ARA:PWY-6623,1,0.9982834890933987,0,3,salicylate glucosides biosynthesis II,BioCyc
ARA:PWY-6624,1,0.9987944992616979,0,2,salicylate glucosides biosynthesis III,BioCyc
ARA:PWY-6663,1,0.9904723474500962,0,19,plant sterol biosynthesis II,BioCyc
ARA:PWY-6666,1,0.9988743884588311,0,2,pyocyanin biosynthesis,BioCyc
ARA:PWY-6673,1,0.995278297441441,0,9,caffeoylglucarate biosynthesis,BioCyc
ARA:PWY-6707,1,0.9995161971687465,0,1,gallate biosynthesis,BioCyc
ARA:PWY-6710,1,0.9971668569347656,0,5,poly-hydroxy fatty acids biosynthesis,BioCyc
ARA:PWY-6724,1,0.9923734308480104,0,15,starch degradation II,BioCyc
ARA:PWY-6730,1,0.9973599358036521,0,5,methylhalides biosynthesis (plants),BioCyc
ARA:PWY-6733,1,0.978468324600118,0,39,sporopollenin precursors biosynthesis,BioCyc
ARA:PWY-6736,1,0.9984301731284089,0,3,sulfur volatiles biosynthesis,BioCyc
ARA:PWY-6745,1,0.9959382752170367,0,8,phytochelatins biosynthesis,BioCyc
ARA:PWY-6754,1,0.9950777472717999,0,9,S-methyl-5'-thioadenosine degradation I,BioCyc
ARA:PWY-6756,1,0.9966588908201351,0,6,S-methyl-5'-thioadenosine degradation II,BioCyc
ARA:PWY-6762,1,0.9987944992616979,0,2,salicylate glucosides biosynthesis IV,BioCyc
ARA:PWY-6773,1,0.9911408089390996,0,19,"1,3-&beta;-D-glucan biosynthesis",BioCyc
ARA:PWY-6786,1,0.9910996078800468,0,15,detoxification of reactive carbonyls in chloroplasts,BioCyc
ARA:PWY-6787,1,0.9845088637169016,0,27,flavonoid biosynthesis (in equisetum),BioCyc
ARA:PWY-6792,1,0.9938726559187944,0,10,scopoletin biosynthesis,BioCyc
ARA:PWY-6799,1,0.9990170771875045,0,2,fatty acid biosynthesis (plant mitochondria),BioCyc
ARA:PWY-6802,1,0.9989950786348599,0,2,salidroside biosynthesis,BioCyc
ARA:PWY-6803,1,0.9655536376804873,0,65,phosphatidylcholine acyl editing,BioCyc
ARA:PWY-6804,1,0.9974018503142936,0,5,diacylglycerol biosynthesis (PUFA enrichment in oilseed),BioCyc
ARA:PWY-6806,1,0.9984965293587178,0,3,carotenoid cleavage,BioCyc
ARA:PWY-6823,1,0.9885626130045537,0,20,molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-6825,1,0.9953732303143072,0,7,phosphatidylcholine biosynthesis V,BioCyc
ARA:PWY-6837,1,0.9932065913527639,0,12,"fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)",BioCyc
ARA:PWY-6842,1,0.9547009064157006,0,71,glutathione-mediated detoxification II,BioCyc
ARA:PWY-6845,1,0.9984812715783806,0,3,nitric oxide biosynthesis (plants),BioCyc
ARA:PWY-6890,1,0.9990129763055243,0,2,4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis,BioCyc
ARA:PWY-6898,1,0.9952923044545717,0,8,thiamine salvage III,BioCyc
ARA:PWY-6902,1,0.9904020133331257,0,15,chitin degradation II (Vibrio),BioCyc
ARA:PWY-6908,1,0.993550718155027,0,11,thiamine diphosphate biosynthesis IV (eukaryotes),BioCyc
ARA:PWY-6909,1,0.9994142297278725,0,1,thiazole biosynthesis III (eukaryotes),BioCyc
ARA:PWY-6910,1,0.999499057104232,0,1,hydroxymethylpyrimidine salvage,BioCyc
ARA:PWY-6922,1,0.9963172204924143,0,7,L-N&delta;-acetylornithine biosynthesis,BioCyc
ARA:PWY-6927,1,0.9926659559228171,0,14,chlorophyll a degradation II,BioCyc
ARA:PWY-6930,1,0.9976332349533356,0,4,phenolic malonylglucosides biosynthesis,BioCyc
ARA:PWY-6931,1,0.9995196839413555,0,1,seleno-amino acid detoxification and volatilization I,BioCyc
ARA:PWY-6932,1,0.9989614114318257,0,2,selenate reduction,BioCyc
ARA:PWY-6936,1,0.9945942869613968,0,10,seleno-amino acid biosynthesis,BioCyc
ARA:PWY-6938,1,0.9989975941204301,0,2,NADH repair,BioCyc
ARA:PWY-695,1,0.9933575428404797,0,12,abscisic acid biosynthesis,BioCyc
ARA:PWY-6952,1,0.9910093308218156,0,18,glycerophosphodiester degradation,BioCyc
ARA:PWY-6959,1,0.9916417971493751,0,16,L-ascorbate degradation V,BioCyc
ARA:PWY-6963,1,0.9935233686897642,0,13,ammonia assimilation cycle I,BioCyc
ARA:PWY-6964,1,0.9939959727088445,0,12,ammonia assimilation cycle II,BioCyc
ARA:PWY-6982,1,0.9926887075882882,0,14,umbelliferone biosynthesis,BioCyc
ARA:PWY-699,1,0.9944209000022198,0,11,brassinosteroid biosynthesis I,BioCyc
ARA:PWY-701,1,0.9994347010764726,0,1,L-methionine degradation II,BioCyc
ARA:PWY-702,1,0.9905866673056604,0,18,L-methionine biosynthesis II,BioCyc
ARA:PWY-7036,1,0.9840535907627521,0,31,very long chain fatty acid biosynthesis II,BioCyc
ARA:PWY-7039,1,0.9737457670703109,0,52,"phosphatidate metabolism, as a signaling molecule",BioCyc
ARA:PWY-7047,1,0.9962499192031764,0,7,malate-oxaloacetate shuttle I,BioCyc
ARA:PWY-7048,1,0.9972552356752147,0,5,malate-oxaloacetate shuttle II,BioCyc
ARA:PWY-7060,1,0.9964614884672479,0,7,ornithine-citrulline shuttle,BioCyc
ARA:PWY-7061,1,0.9970671512457857,0,6,glutamate-glutamine shuttle,BioCyc
ARA:PWY-7067,1,0.9973826591357768,0,4,betulinate biosynthesis,BioCyc
ARA:PWY-7068,1,0.9973826591357768,0,4,ursolate biosynthesis,BioCyc
ARA:PWY-7071,1,0.9987563174926367,0,2,steviol glucoside biosynthesis (rebaudioside A biosynthesis),BioCyc
ARA:PWY-7101,1,0.9982844437837538,0,3,5-deoxystrigol biosynthesis,BioCyc
ARA:PWY-7120,1,0.9967554913090767,0,6,esterified suberin biosynthesis,BioCyc
ARA:PWY-7140,1,0.9984302738204367,0,3,myricetin gentiobioside biosynthesis,BioCyc
ARA:PWY-7158,1,0.998902093688183,0,2,L-phenylalanine degradation V,BioCyc
ARA:PWY-7170,1,0.9989206411736598,0,2,phytochromobilin biosynthesis,BioCyc
ARA:PWY-7176,1,0.9842787643954071,0,29,UTP and CTP de novo biosynthesis,BioCyc
ARA:PWY-7177,1,0.9912740558355024,0,18,UTP and CTP dephosphorylation II,BioCyc
ARA:PWY-7183,1,0.9946152387355413,0,11,pyrimidine nucleobases salvage I,BioCyc
ARA:PWY-7184,1,0.9806009196921481,0,35,pyrimidine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7185,1,0.9857926991162864,0,29,UTP and CTP dephosphorylation I,BioCyc
ARA:PWY-7186,1,0.9920404520920022,0,15,superpathway of scopolin and esculin biosynthesis,BioCyc
ARA:PWY-7187,1,0.9866528065748439,0,23,pyrimidine deoxyribonucleotides de novo biosynthesis II,BioCyc
ARA:PWY-7193,1,0.991778892944,0,16,pyrimidine ribonucleosides salvage I,BioCyc
ARA:PWY-7196,1,0.9750912187867161,0,47,superpathway of pyrimidine ribonucleosides salvage,BioCyc
ARA:PWY-7197,1,0.9910648080694088,0,15,pyrimidine deoxyribonucleotide phosphorylation,BioCyc
ARA:PWY-7199,1,0.9938297092140669,0,11,pyrimidine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7200,1,0.9849221887324718,0,26,superpathway of pyrimidine deoxyribonucleoside salvage,BioCyc
ARA:PWY-7204,1,0.9913160361393472,0,16,pyridoxal 5'-phosphate salvage II (plants),BioCyc
ARA:PWY-7205,1,0.991128973580796,0,15,CMP phosphorylation,BioCyc
ARA:PWY-7206,1,0.995491811663694,0,7,pyrimidine deoxyribonucleotides dephosphorylation,BioCyc
ARA:PWY-7208,1,0.9789365551335899,0,40,superpathway of pyrimidine nucleobases salvage,BioCyc
ARA:PWY-7211,1,0.9674227673859936,0,61,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7213,1,0.9964512086873782,0,7,wogonin metabolism,BioCyc
ARA:PWY-7219,1,0.9747080646206191,0,42,adenosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7221,1,0.9894924896338791,0,19,guanosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7224,1,0.9918576617671685,0,14,purine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7226,1,0.9930094692116379,0,12,guanosine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7227,1,0.9930094692116379,0,12,adenosine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7238,1,0.9809136006489797,0,39,sucrose biosynthesis II,BioCyc
ARA:PWY-724,1,0.9790273531859871,0,41,"superpathway of L-lysine, L-threonine and L-methionine biosynthesis II",BioCyc
ARA:PWY-7250,1,0.9994471975177945,0,1,[2Fe-2S] iron-sulfur cluster biosynthesis,BioCyc
ARA:PWY-7267,1,0.9976553652108779,0,4,anthocyanin biosynthesis (pelargonidin 3-O-glucoside),BioCyc
ARA:PWY-7270,1,0.977964741737254,0,41,L-methionine salvage cycle II (plants),BioCyc
ARA:PWY-7325,1,0.9994719310050306,0,1,salvigenin biosynthesis,BioCyc
ARA:PWY-7343,1,0.9932481121385949,0,14,UDP-glucose biosynthesis,BioCyc
ARA:PWY-7344,1,0.9969955547748252,0,6,UDP-D-galactose biosynthesis,BioCyc
ARA:PWY-7346,1,0.9973897684555837,0,5,UDP-&alpha;-D-glucuronate biosynthesis (from UDP-glucose),BioCyc
ARA:PWY-735,1,0.9870242384663175,0,25,jasmonic acid biosynthesis,BioCyc
ARA:PWY-7356,1,0.9923159411767007,0,13,thiamine salvage IV (yeast),BioCyc
ARA:PWY-7388,1,0.9836718615799466,0,30,"octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)",BioCyc
ARA:PWY-7398,1,0.9891412809843733,0,19,coumarins biosynthesis (engineered),BioCyc
ARA:PWY-7416,1,0.9855830414845306,0,27,"phospholipid remodeling (phosphatidylcholine, yeast)",BioCyc
ARA:PWY-7432,1,0.9940099007250982,0,11,"L-phenylalanine biosynthesis III (cytosolic, plants)",BioCyc
ARA:PWY-7436,1,0.9983187923274687,0,3,vitamin E biosynthesis (tocotrienols),BioCyc
ARA:PWY-7450,1,0.9857609864033389,0,25,anthocyanidin modification (Arabidopsis),BioCyc
ARA:PWY-7468,1,0.9987944992616979,0,2,benzoyl-&beta;-D-glucopyranose biosynthesis,BioCyc
ARA:PWY-7528,1,0.984571269368326,0,28,L-methionine salvage cycle I (bacteria and plants),BioCyc
ARA:PWY-7560,1,0.9910783456507579,0,17,methylerythritol phosphate pathway II,BioCyc
ARA:PWY-7590,1,0.9984834958416926,0,3,"(7Z,10Z,13Z)-hexadecatrienoate biosynthesis",BioCyc
ARA:PWY-762,1,0.9948297703967224,0,9,phospholipid desaturation,BioCyc
ARA:PWY-7625,1,0.9974308979637513,0,5,phosphatidylinositol biosynthesis II (eukaryotes),BioCyc
ARA:PWY-7640,1,0.9989847687087761,0,2,neophaseic acid biosynthesis,BioCyc
ARA:PWY-782,1,0.9952729606437245,0,9,glycolipid desaturation,BioCyc
ARA:PWY-7985,1,0.9984669645335632,0,3,oxalate degradation VI,BioCyc
ARA:PWY-801,1,0.9974750334827195,0,5,L-homocysteine and L-cysteine interconversion,BioCyc
ARA:PWY-82,1,0.9985542146757461,0,3,UDP-L-arabinose biosynthesis II (from L-arabinose),BioCyc
ARA:PWY-83,1,0.999440953339024,0,1,monolignol glucosides biosynthesis,BioCyc
ARA:PWY-84,1,0.9987235365274497,0,2,resveratrol biosynthesis,BioCyc
ARA:PWY-841,1,0.9930094692116379,0,12,superpathway of purine nucleotides de novo biosynthesis I,BioCyc
ARA:PWY-861,1,0.9955088961026541,0,8,dhurrin biosynthesis,BioCyc
ARA:PWY-882,1,0.9868353634476412,0,26,L-ascorbate biosynthesis I (L-galactose pathway),BioCyc
ARA:PWY-922,1,0.9901000349970891,0,20,mevalonate pathway I,BioCyc
ARA:PWY0-1021,1,0.9984598172868702,0,3,L-alanine biosynthesis III,BioCyc
ARA:PWY0-1182,1,0.9961054592894061,0,8,trehalose degradation II (trehalase),BioCyc
ARA:PWY0-1264,1,0.9951504388117679,0,10,biotin-carboxyl carrier protein assembly,BioCyc
ARA:PWY0-1313,1,0.9951159225927035,0,10,acetate conversion to acetyl-CoA,BioCyc
ARA:PWY0-1319,1,0.9934781820581046,0,13,CDP-diacylglycerol biosynthesis II,BioCyc
ARA:PWY0-1325,1,0.9970937131148196,0,6,superpathway of L-asparagine biosynthesis,BioCyc
ARA:PWY0-1507,1,0.9948621719922154,0,10,biotin biosynthesis from 8-amino-7-oxononanoate I,BioCyc
ARA:PWY0-1535,1,0.9988646106312057,0,2,D-serine degradation,BioCyc
ARA:PWY0-162,1,0.9812997681600932,0,35,superpathway of pyrimidine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY0-166,1,0.9850967300857867,0,26,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli),BioCyc
ARA:PWY0-461,1,0.9969926457252762,0,5,L-lysine degradation I,BioCyc
ARA:PWY0-501,1,0.996283252998847,0,6,lipoate biosynthesis and incorporation I,BioCyc
ARA:PWY0-541,1,0.998070109408134,0,4,cyclopropane fatty acid (CFA) biosynthesis,BioCyc
ARA:PWY0-662,1,0.9959514254800189,0,8,PRPP biosynthesis I,BioCyc
ARA:PWY0A-6303,1,0.9927026141507744,0,13,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY1F-353,1,0.9984945496652519,0,3,glycine betaine biosynthesis III (plants),BioCyc
ARA:PWY1F-467,1,0.998022596000557,0,4,"phenylpropanoid biosynthesis, initial reactions",BioCyc
ARA:PWY1F-823,1,0.9977252505742485,0,4,leucopelargonidin and leucocyanidin biosynthesis,BioCyc
ARA:PWY1F-FLAVSYN,1,0.9818707152563876,0,33,flavonoid biosynthesis,BioCyc
ARA:PWY3DJ-35471,1,0.9979520354710869,0,4,L-ascorbate biosynthesis IV,BioCyc
ARA:PWY3O-450,1,0.9944100493747327,0,11,phosphatidylcholine biosynthesis I,BioCyc
ARA:PWY490-4,1,0.9978260301735643,0,4,L-asparagine biosynthesis III (tRNA-dependent),BioCyc
ARA:PWY4FS-10,1,0.9988478950279014,0,2,scopolin biosynthesis,BioCyc
ARA:PWY4FS-11,1,0.9980508515696548,0,4,L-ascorbate biosynthesis II (L-gulose pathway),BioCyc
ARA:PWY4FS-12,1,0.9990059775884362,0,2,VTC2 cycle,BioCyc
ARA:PWY4FS-13,1,0.9990059775884362,0,2,extended VTC2 cycle,BioCyc
ARA:PWY4FS-2,1,0.9926054977171125,0,15,phosphatidylcholine biosynthesis II,BioCyc
ARA:PWY4FS-3,1,0.9952771160712366,0,9,phosphatidylcholine biosynthesis III,BioCyc
ARA:PWY4FS-4,1,0.9952771160712366,0,9,phosphatidylcholine biosynthesis IV,BioCyc
ARA:PWY4FS-5,1,0.9897003997589906,0,20,superpathway of phosphatidylcholine biosynthesis,BioCyc
ARA:PWY4FS-6,1,0.9934364085697941,0,13,phosphatidylethanolamine biosynthesis II,BioCyc
ARA:PWY4FS-7,1,0.9911929843023627,0,17,phosphatidylglycerol biosynthesis I (plastidic),BioCyc
ARA:PWY4FS-8,1,0.9835864601098472,0,32,phosphatidylglycerol biosynthesis II (non-plastidic),BioCyc
ARA:PWY66-21,1,0.9831726011791578,0,34,ethanol degradation II,BioCyc
ARA:PWY66-423,1,0.9971014082054322,0,5,"fructose 2,6-bisphosphate biosynthesis",BioCyc
ARA:PWYDQC-4,1,0.9962230608438599,0,7,indole-3-acetate biosynthesis I,BioCyc
ARA:PWYQT-1,1,0.997102489827737,0,6,lysine degradation III,BioCyc
ARA:PWYQT-4427,1,0.9985172473628197,0,3,sulfoquinovosyl diacylglycerol biosynthesis,BioCyc
ARA:PWYQT-4429,1,0.9966211098003971,0,7,CO2 fixation into oxaloacetate (anaplerotic),BioCyc
ARA:PWYQT-4432,1,0.9974859919488986,0,5,glutathione degradation,BioCyc
ARA:PWYQT-4433,1,0.9980198866129603,0,4,CA1P biosynthesis,BioCyc
ARA:PWYQT-4445,1,0.9886284102792692,0,23,pyrimidine salvage pathway,BioCyc
ARA:PWYQT-4449,1,0.9901722043236602,0,16,polyisoprenoid biosynthesis,BioCyc
ARA:PWYQT-4450,1,0.9952616763272729,0,9,"aliphatic glucosinolate biosynthesis, side chain elongation cycle",BioCyc
ARA:PWYQT-4466,1,0.972755619654324,0,54,superpathway of sucrose and starch metabolism I (non-photosynthetic tissue),BioCyc
ARA:PWYQT-4470,1,0.9980620160644831,0,4,&gamma;-glutamyl cycle (plant pathway),BioCyc
ARA:PWYQT-4471,1,0.9685943111101573,0,54,glucosinolate biosynthesis from dihomomethionine,BioCyc
ARA:PWYQT-4472,1,0.9860305618049027,0,25,glucosinolate biosynthesis from trihomomethionine,BioCyc
ARA:PWYQT-4473,1,0.9860305618049027,0,25,glucosinolate biosynthesis from tetrahomomethionine,BioCyc
ARA:PWYQT-4474,1,0.9860305618049027,0,25,glucosinolate biosynthesis from pentahomomethionine,BioCyc
ARA:PWYQT-4475,1,0.9829770356251352,0,31,glucosinolate biosynthesis from hexahomomethionine,BioCyc
ARA:PWYQT-4476,1,0.9958021632653207,0,8,indole glucosinolate activation (herbivore attack),BioCyc
ARA:PWYQT-4477,1,0.9909657540803357,0,16,indole glucosinolate activation (intact plant cell),BioCyc
ARA:PWYQT-4481,1,0.975686655407373,0,44,TCA cycle variation V (plant),BioCyc
ARA:PWYQT-4482,1,0.9953723983728369,0,9,CDP-diacylglycerol biosynthesis IV,BioCyc
ARA:PWYQT-62,1,0.9830903206122242,0,33,superpathway of proto- and siroheme biosynthesis,BioCyc
ARA:PWYQT-94,1,0.9906943678015065,0,17,superpathway of polyamine biosynthesis,BioCyc
ARA:PYRIDNUCSYN-PWY,1,0.9964222600937278,0,7,NAD biosynthesis I (from aspartate),BioCyc
ARA:PYRUVDEHYD-PWY,1,0.9884387890710997,0,22,pyruvate decarboxylation to acetyl CoA,BioCyc
ARA:RIBOSYN2-PWY,1,0.9926756309837539,0,14,flavin biosynthesis I (bacteria and plants),BioCyc
ARA:SAM-PWY,1,0.9961921984971007,0,7,S-adenosyl-L-methionine biosynthesis,BioCyc
ARA:SERSYN-PWY,1,0.996747297693695,0,6,L-serine biosynthesis,BioCyc
ARA:SUCSYN-PWY,1,0.9790680256647758,0,40,sucrose biosynthesis I (from photosynthesis),BioCyc
ARA:SULFMETII-PWY,1,0.9952483880135585,0,9,sulfate reduction II (assimilatory),BioCyc
ARA:THIOREDOX-PWY,1,0.9867397942245487,0,19,thioredoxin pathway,BioCyc
ARA:THRESYN-PWY,1,0.9857490737988938,0,28,superpathway of L-threonine biosynthesis,BioCyc
ARA:TRESYN-PWY,1,0.9863276910035155,0,28,trehalose biosynthesis I,BioCyc
ARA:TRIGLSYN-PWY,1,0.9658955646829204,0,66,diacylglycerol and triacylglycerol biosynthesis,BioCyc
ARA:TRPSYN-PWY,1,0.9887561158004138,0,22,L-tryptophan biosynthesis,BioCyc
ARA:TYRFUMCAT-PWY,1,0.9924383711407371,0,14,L-tyrosine degradation I,BioCyc
ARA:UDPNACETYLGALSYN-PWY,1,0.9952397841614161,0,8,UDP-N-acetyl-D-glucosamine biosynthesis II,BioCyc
ARA:VALDEG-PWY,1,0.9846660900593955,0,30,L-valine degradation I,BioCyc
ARA:VALSYN-PWY,1,0.9916462882661893,0,17,L-valine biosynthesis,BioCyc
ARA:XYLCAT-PWY,1,0.9980511337676677,0,4,xylose degradation I,BioCyc
ARA:DETOX1-PWY-1,1.0000000000000002,0.9847366283368199,0,28,reactive oxygen species degradation,BioCyc
